Apigenin, in the case of melanoma (melanoma xenograft model with A375, A2058, and RPMI-7951), strongly suppresses the IFN-γ-induced activation of STAT1, leading to decreased PD-L1 expression; thus, sensitizing them to T cell-mediated killings [172]. The gene discussed is IFNG; the disease is melanoma.